Medical Sciences Program, Indiana University, Bloomington, Indiana.
Department of Cellular and Molecular Medicine, Stem Cell Program and Institute for Genomic Medicine, University of California at San Diego, San Diego, United States.
Elife. 2017 Sep 19;6:e28625. doi: 10.7554/eLife.28625.
ADAR proteins alter gene expression both by catalyzing adenosine (A) to inosine (I) RNA editing and binding to regulatory elements in target RNAs. Loss of ADARs affects neuronal function in all animals studied to date. lacking ADARs exhibit reduced chemotaxis, but the targets responsible for this phenotype remain unknown. To identify critical neural ADAR targets in , we performed an unbiased assessment of the effects of ADR-2, the only A-to-I editing enzyme in , on the neural transcriptome. Development and implementation of publicly available software, identified 7361 A-to-I editing events across the neural transcriptome. Intersecting the neural editome with associated gene expression changes, revealed an edited mRNA, , whose neural expression is dependent on deamination. Restoring expression in deficient neural cells rescued the chemotaxis defect, providing the first evidence that neuronal phenotypes of ADAR mutants can be caused by altered gene expression.
ADAR 蛋白通过催化腺苷(A)向肌苷(I)的 RNA 编辑以及与靶 RNA 中的调节元件结合来改变基因表达。迄今为止,ADAR 的缺失会影响所有研究过的动物的神经元功能。缺乏 ADAR 的动物表现出趋化性降低,但负责这种表型的靶标尚不清楚。为了鉴定 中关键的神经 ADAR 靶标,我们对 中唯一的 A 到 I 编辑酶 ADR-2 对神经转录组的影响进行了无偏评估。通过开发和应用公共可用的软件,我们在整个神经转录组中鉴定了 7361 个 A 到 I 的编辑事件。将神经编辑组与 相关的基因表达变化进行交集,揭示了一个编辑的 mRNA, ,其神经表达依赖于脱氨酶。在 缺乏的神经细胞中恢复 的表达挽救了趋化性缺陷,这首次提供了证据表明 ADAR 突变体的神经元表型可能是由基因表达改变引起的。